prevalence of CIN3+ decreases due to HPV vaccination, and also as new screening and triage tests are introduced. doi: 10.1093/jncics/pkac086. For example, HPV primary testing or The new management guidelines are lengthy and include six supporting papers (see Resources section). This algorithm should not be used to treat pregnant women. endobj Publications of the American College of Obstetrician and Gynecologists are protected by copyright and all rights are reserved. 1075 0 obj <>stream Lower Anogenital Squamous Terminology (LAST): this term refers to two-tiered pathology criteria for The Steering Committee, Working Group members, and additional contributing authors for the ASCCP Risk Based appropriate ASCCP management guidelines for women with abnormal screening tests. Shared decision making should be used when considering expedited treatment, especially for patients with concerns about the potential impact of treatment on pregnancy outcomes. Introduction of risk- based guidelines in 2012 was a conceptual In such cases, using the 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors2 is acceptable. Pap Test: A test in which cells are taken from the cervix (or vagina) to look for signs of cancer. endobj Available at: Risk estimate tables supporting the 2019 ASCCP risk-based management consensus guidelines. found when histology or cytology is inconclusive such as a result of LSIL cannot rule out HSIL. 2f8 Hf8*@r9MXNw6JXbc```3=20(.bbc`Sb0 Z cotesting at intervals <5 years, or cytology alone at intervals <3 years. Federal government websites often end in .gov or .mil. Updated guidelines published in October 2007 place greater emphasis on testing for high-risk human papillomavirus (HPV). treat). J Low Genit Tract Dis. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented. 4 0 obj Similarly, if a patient had a high-grade cytology result, including atypical squamous cells cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) atypical glandular cells, (AGC) or high grade squamous intraepithelial lesion (HSIL), and did not receive a colposcopy, colposcopy is recommended. 1 0 obj INTRODUCTION. The 2019 ASCCP Risk-Based Management Consensus Guidelines1 represent a paradigm shift from using primarily results-based algorithms to using risk-based management based on a combination of current screening test results and past screening history. This information is not intended for use without professional advice. J Low Genit Tract Dis 2020;24:10231. 3. time. Clinical judgment should always be used when applying a guideline to an individual patient because it is impossible risk of developing cervical precancer or cancer can be estimated using her current screening test results and prior In this case, management of routine screening results is the appropriate selection. In addition, changing the paradigm of 2023 Jan 3;7(1):pkac086. Expression of E4 Protein and HPV Major Capsid Protein (L1) as A Novel Combination in Squamous Intraepithelial Lesions. may email you for journal alerts and information, but is committed See this image and copyright information in PMC. and transmitted securely. Similar considerations exist for a patient who is referred with a moderate Pap smear who has completed child bearing. ACS/ASCCP/ASCP guidelines 1. Health care personnel's perspectives on human papillomavirus (HPV) self-sampling for cervical cancer screening: a pre-implementation, qualitative study. American Society for Colposcopy and Cervical Pathology. The ASCCP Management Guidelines applications were developed by ASCCP. Risk estimates are organized into tables of risk by current test result and history. opinion. <> %PDF-1.6 % %PDF-1.5 Schiffman M, Wentzensen N, Perkins RB, Guido RS. Cytology every three years (liquid or conventional) Recommend against annual Pap smear. HPV infection is the most common sexually transmitted infection in the United States. USPSTF guidelines 13. Routine Screening (within past 5 years): Management of HPV and/or cytology results obtained during routine cervical cancer screening and for patients where prior screening results did not result in colposcopy, but where risk was too high to return to routine screening. defined by IARC, including the 12 types that are considered Class 1 carcinogens, plus type 68 which is considered a Pathology (ASCCP), and the American Society for Clinical Pathology.5 In this update of the ACS guideline for cervical can-cer screening, we recommend that cervical cancer screen-ing should begin in average-risk individuals with a cervix at age 25 years and cease at age 65 years and that the pre-ferred strategy for regular screening is primary HPV This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. occurs at shorter intervals than those recommended for routine screening. A Pap test, also called a Pap smear or cervical cytology, is a way of screening for cervical cancer. 2. Am J Obstet Gynecol 2007;197:34655. Consistent with prior guidance, screening should begin at age 21 years, and screening recommendations remain unchanged for average-risk individuals aged 21-29 years and those who are older than 65 years Table 1. 1044 0 obj <>/Filter/FlateDecode/ID[<51FC2DB85E610A4EB791D667E0A1A1A7>]/Index[1017 59]/Info 1016 0 R/Length 110/Prev 455981/Root 1018 0 R/Size 1076/Type/XRef/W[1 3 1]>>stream Epub 2020 May 23. Algorithms and/or risk estimates are shown when available. 2 0 obj Some error has occurred while processing your request. A Question to the 2019 ASCCP Risk-Based Management Consensus Guidelines. official website and that any information you provide is encrypted | Terms and Conditions of Use. While ACOG makes every effort to present accurate and reliable information, this publication is provided as is without any warranty of accuracy, reliability, or otherwise, either express or implied. On June 12, 2020, the U.S. Food and Drug Administration approved adding the prevention of head and neck cancers caused by HPV as an indication for the nonavalent HPV vaccine (Gardasil 9). The College's publications may not be reproduced in any form or by any means without written permission from the copyright owner. endobj 2020;24(2):102131. See permissionsforcopyrightquestions and/or permission requests. endstream endobj startxref receives cervical screening results at reduced or no cost from commercial research partners (Qiagen, Roche, BD, MobileODT, Arbor Vita) for independent evaluations of screening methods and strategies. 3. HPV vaccination is ideally administered at 11 or 12 years of age and may be administered as early as nine years of age, irrespective of the patient's sex. 9zSM_XChtb^xqUNDoEJo+'HDT--XZwoEFVg%oez) +r]ii{;SLLLZ2V=waB($AzIq 32FQ+~PyYWmTwX70"b_SL>nG#%c#>h^k_"KSqyKD&zcTY.0CM[oBN!rx#jRw;44 .8+Nd6o52 //i\`ycq/ &!s The ASCCP guidelines are free to review in PDF form and are probably your most useful resource. Therefore, incorporating HPV testing into risk stratification and recommendations for surveillance following abnormal results was an important part of the 2019 guidelines. A.-B.M. Schwameis R, Ganhoer-Schimboeck J, Hadjari VL, Hefler L, Bergmeister B, Kssel T, Gittler G, Steindl-Schoenhuber T, Grimm C. Cancers (Basel). Although most HPV infections are transient and subclinical, some lead to clinical manifestations ranging from benign papillomas or warts to intraepithelial lesions. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. To help physicians navigate this information and to facilitate implementation, a free web-based decision management tool has been developed (https://app.asccp.org/). Because the new Risk-Based recommendations for the practice of colposcopy. Clinical Action Threshold: this term refers to risk levels that prompt different clinical management Kruse GR, Lykken JM, Kim EJ, Haas JS, Higashi RT, Atlas SJ, McCarthy AM, Tiro JA, Silver MI, Skinner CS, Kamineni A. JNCI Cancer Spectr. clinical study, scientific report, draft regulation) is released that requires an immediate or rapid response, particularly if it is anticipated that it will generate a multitude of inquiries. The 2019 ASCCP Risk-Based Management Consensus Guidelines 1 represent a paradigm shift from using primarily results-based algorithms to using risk-based management based on a combination of current screening test results and past screening history. MeSH Perkins RB, Guido RS, Castle PE, et al. Allow for a more complete and precise estimation of risk, Provide more appropriate intervention for high-risk individuals, Recommend less intervention for low-risk individuals, Allow for the future addition of new risk modifiers and screening and management technologies. National Library of Medicine -, Wright TC, Massad LS, Dunton CJ, et al. effective and invasive cervical cancer can develop in women participating in such programs. %%EOF Recommendations of colposcopy, treatment, or surveillance will be based on a patient's risk of CIN 3+ determined by a combination of current results and past history (including unknown history). The risk database will continue to be updated as new testing methods and follow-up data emerge, and the new framework will allow management to be adjusted accordingly and consistently. 2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. 2020 Oct;24(4):426. doi: 10.1097/LGT.0000000000000562. The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide recommendations for the care of patients with abnormal cervical cancer screening results. Human Papillomavirus (HPV) Vaccine Guidelines The American Cancer Society recommends HPV vaccination for boys and girls between ages 9 and 12. Evaluating the Feasibility of Machine-Learning-Based Predictive Models for Precancerous Cervical Lesions in Patients Referred for Colposcopy. This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. Chan School of Public Health, Boston, MA, 9University of California, Los Angeles, CA, 10Northwestern University, Feinberg School of Medicine-Northwestern Memorial Hospital, Chicago, IL, 11Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, 12University of California, San Francisco, San Francisco, California, 13Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, 14Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, Bethesda, MD. For individuals aged 25 or older screened with cytology alone, the 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors2 are recommended for management of abnormal results. Expedited treatment: this term means treatment without confirmatory colposcopic biopsy (e.g., see and than in previous iterations of guidelines. Beyond the Management tab, there are two other tabs. The recommendation is for colposcopy. New evidence indicates that risk remains elevated for at least 25 years, with no evidence that treated patients ever return to risk levels compatible with 5-year intervals. Read terms. %PDF-1.5 % Any person with a cervix should be screened, regardless of gender identity, sexual orientation . Risk factors for HPV infection include early sexual contact, having multiple sex partners, a history of other sexually transmitted infections, HIV infection, an immunocompromised state, and not using barrier protection during sex.3,13,14, Persistent oral and genital HPV infections are associated with alcohol use and smoking.15,16 There is some evidence that human leukocyte antigen type may impact an individual's ability to clear HPV viruses.17 Although several factors have been associated with an increased risk of progression to cervical disease (e.g., age, body mass index, income, oral contraceptive use, race/ethnicity, smoking), persistent high-risk HPV infection is the most significant risk factor for progression.18,19, Infection with a low-risk HPV type does not preclude infection with a concomitant high-risk type. ZKlX#`Q)s4 OhMaoJDk4*L!ivm *k^xtY3 u|yHU& Df3u high quality evidence, and in these situations the guidelines have, by necessity, been based on consensus expert Disclaimer. Available at: ASCCP. strategies. If you are 21 to 29 Have a Pap test alone every 3 years. In some patients, persistent infection with high-risk mucosal types, especially HPV-16 and HPV-18, causes anal, cervical, oropharyngeal, penile, vaginal, and vulvar cancers. Essential Changes From Prior Management Guidelines. <> PhD; George Sawaya, MD; Mark Schiffman, MD; Kathryn Sharpless, MD, PhD; Katie Smith, MD, MS; Elizabeth Stier, MD; J Low Genit Tract Dis 2020;24:102-31. He has been the overall PI or local PI for clinical trials from Johnson&Johnson, Pfizer, Iovance, and Inovio. revised guidelines provide a framework for incorporating new data and technologies as ongoing incremental 140, Management of Abnormal Cervical Cancer Screening Test Results and Cervical Cancer Precursors. Schiffman and Wentzensen) receives cervical screening results at reduced or no cost from commercial research partners (Qiagen, Roche, BD, MobileODT, Arbor Vita) for independent evaluations of screening methods and strategies, Dr. Moscicki: Merck and GSK, Advisory Board member, Dr. Guido: Inovio Pharmaceuticals DSMB, ASCCP Consultant. Table 1. As a result, the risk estimates associated with some screening test combinations may change. This content is owned by the AAFP. 17-19 Patients with a history of abnormal test results require more frequent testing as recommended by the ASCCP. P.E.C. -, Massad LS, Einstein MH, Huh WK, et al. This was a large consensus effort involving several clinical organizations, federal agencies, and patient representatives. marked Pap smear, repeat colposcopy MAY not change management even if negative, so it may be appropriate to proceed with a diagnostic excisional procedure if review of material is not an option. Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. Updated guidelines were needed to incorporate these changes. through a program of screening and management of cervical precancer, no screening or treatment modality is 100% Unlike the 2012 ASCCP guidelines that relied on test results-based algorithms, the new consensus guidelines follow a risk-based approach to determine the need for surveillance, colposcopy, or treatment. Drs. 4) Notice now we've moved to a screen where we can enter testing results. 2) Notice this recommendation looks different. Guidelines are to increase accuracy and reduce complexity for providers and patients. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. The https:// ensures that you are connecting to the if 25yo Guideline IId. % Screening for HPV infection is effective in identifying precancerous lesions and allows for interventions that can prevent the development of cancer. The prevalence of cutaneous warts is highest in school-aged children (up to 30%), then declines with advancing age.2 HPV infection is the most common sexually transmitted infection in the United States. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. In 2019, the ASCCP updated consensus guidelines for the management of screening abnormalities, which are available as an open-access document on the Journal of Lower Genital Tract Disease website. & D@eLiat2D_*0N-!d0.a*#h & 2e Copyright, 2002, 2006, 2013, 2019, 2020 ASCCP. %%EOF Reprinted with permission from Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. endstream endobj startxref We don't have any prior history in this particular case. Nayar R, Chhieng DC, Crothers B, Darragh TM, Davey DD, Eisenhut C, Goulart R, Huang EC, Tabbara SO. J Low Genit Tract Dis 2020;24:144-7. 3 0 obj J Low Genit Tract Dis 2020;24:10231. 5) The confirmation pageensures that all the information was entered correctly. variables to consider, the 2019 guidelines further align management recommendations with current understanding of time: Negative HPV test or cotest within 5 years. Careers. your express consent. The National Cancer Institute (including M.S. The ability to adjust to the rapidly emerging science is critical for the 2. Do not perform cervical cytology (Pap test) or HPV screening in immunocompetent women younger than 21 years. The new Risk-Based Management Consensus Guidelines have several important differences from the 2012 Guidelines, 4. You may be trying to access this site from a secured browser on the server. Copyright, 2002, 2006, 2013, 2019, 2020, 2021 ASCCP. FOIA Surveillance: this term refers to repeat testing (HPV primary screening, cotesting, or cytology alone), that endstream endobj startxref Erin Nelson, MD; Akiva Novetsky, MD, MS; Rebecca Perkins, MD; Jeffrey Quinlan, MD; Mona Saraiya, MD; Debbie Saslow, Clinical Practice Listserv (Members Only). contributed equally to the development of this manuscript and are co-first authors. As of April 2021, the cost for the mobile app is $10. By using the app, you agree to the Terms of Use and Privacy Policy. Management Consensus Guidelines Committee includes: Cervical cancer screening with Pap and/or human papillomavirus (HPV) tests is recommended starting between the ages of 21 and 25 years. The American College of Obstetricians and Gynecologists reviews its publications regularly; however, its publications may not reflect the most recent evidence. Conversely, if a patient has a negative HPV test or co-test following a low-grade result for which colposcopy was previously recommended but not performed, repeating an HPV test or co-test in 1 year is acceptable. Clearly Most HPV-related cancers are believed to be caused by sexual spread of the virus. 2022 Dec 6;12(12):3066. doi: 10.3390/diagnostics12123066. The CIN 3+ risks estimates were calculated based on data from a prospective longitudinal cohort of patients from Kaiser Permanente Northern California and validated using several other data sets. Women 30-65 and older who have had 3 consecutive negative Pap test and who have no history of CIN2 or 3, etc. Mixed-quality randomized controlled trials of disease-oriented outcomes, Consistent findings from a Cochrane review of randomized controlled trials of disease-oriented outcomes; evidence-based practice guideline, Consistent findings from randomized controlled trials; evidence-based practice guidelines. ; 24 ( 4 ):426. doi: 10.3390/diagnostics12123066 21 to 29 have Pap. Cancer can develop in women participating in such programs information is not for! He has been the overall PI or local PI for clinical trials Johnson. This term means treatment without confirmatory colposcopic biopsy ( e.g., see and than previous! Found when histology or cytology is inconclusive such as a Novel Combination in Intraepithelial!, also called a Pap test: a test in which cells are taken from the guidelines., 2002, 2006, 2013, 2019, 2020, 2021 ASCCP have any prior history this... ) to look for signs of cancer Guido RS manuscript and are co-first authors identifying Precancerous and! Publications may not reflect the most common sexually transmitted infection in the States... On testing for high-risk human papillomavirus ( HPV ) Dis 2020 ; 24:10231 you provide is encrypted Terms! 3, etc % screening for cervical cancer can develop in women participating in programs... Referred for colposcopy guidelines published in October 2007 place greater emphasis on testing for high-risk human papillomavirus HPV! Permission from the 2012 guidelines, 4 where we can enter testing results a Pap! Are 21 to 29 have a Pap smear HPV infections are transient and,. In Patients referred for colposcopy for a patient who is referred with a moderate Pap smear or cervical,... That all the information was entered correctly primary testing or the new Management guidelines are lengthy and six. Risk stratification and recommendations for the Management of women with abnormal cervical.... Papillomavirus ( HPV ) self-sampling for cervical cancer screening tests Society recommends HPV vaccination and..., changing the paradigm of 2023 Jan 3 ; 7 ( 1 ):.... $ 10 cost for the Management of women with abnormal cervical cancer screening.. By any means without written permission from the 2012 guidelines, 4 warts to Intraepithelial.! And Privacy Policy, but is committed see this image and copyright information in PMC completed child bearing as screening. Cancer screening: a test in which cells are taken from the 2012 guidelines, 4 has! Be reproduced in any form or by any means without written permission from the copyright.... Identity, sexual orientation primary testing or the new Risk-Based recommendations for the Management of women with cervical... Invasive cervical cancer screening: a pre-implementation, qualitative study those recommended for routine screening ; 12 12., you agree to the if 25yo Guideline IId enter testing results by. Intraepithelial Lesions trials from Johnson & Johnson, Pfizer, Iovance, and also as new screening and tests..., see and than in previous iterations of guidelines:426. doi: 10.1097/LGT.0000000000000562 tests and precursors. Screening in immunocompetent women younger than 21 years prior history in this particular case $! Have a Pap smear who has completed child bearing, HPV primary testing the! Are lengthy and include six supporting papers ( see Resources section ) infection in the United States a! Publications of the 2019 ASCCP Risk-Based Management consensus guidelines for abnormal cervical cancer can develop in women participating such... Published in October 2007 place greater emphasis on testing for high-risk human papillomavirus ( HPV ) self-sampling cervical... | Terms and Conditions of Use testing as recommended by the ASCCP Management guidelines are to increase and! Massad LS, Dunton CJ, et al the 2019 ASCCP Risk-Based Management consensus.. And subclinical, some lead to clinical manifestations ranging from benign papillomas or to... To increase accuracy and reduce complexity for providers and Patients moved to a screen where we can testing... Without professional advice you agree to the 2019 guidelines, there are two other tabs, 2013,,... The Terms of Use guidelines have several important differences from the cervix ( or vagina to! Or.mil, federal agencies, and Inovio can prevent the development of this manuscript and are authors... App, you agree to the if 25yo Guideline IId of cancer and reviews! Test result and history ( asccp pap guidelines algorithm 2021 Resources section ) between ages 9 and 12 large consensus involving... N, Perkins RB, Guido RS RB, Guido RS, Castle PE et. Risk estimates associated with some screening test combinations may change pregnant women large consensus effort involving several organizations. Et al iterations of guidelines be caused by sexual spread of the 2019 ASCCP Risk-Based Management consensus guidelines the! Is inconclusive such as a result of LSIL can not rule out HSIL was an part! You agree to the Terms of Use and Privacy Policy // ensures that you are connecting to the 25yo. Screening tests several important differences from the copyright owner risk estimates are organized into of. ( HPV ) therefore, incorporating HPV testing into risk stratification and for. This was a large consensus effort involving several clinical organizations, federal agencies, and as. Et al government websites often end in.gov or.mil the app, you agree to the rapidly science! Development of this manuscript and are co-first authors inconclusive such as a Novel Combination Squamous. 3 years any prior history in this particular case or 3, etc which cells are taken from the (! -, Wright TC, Massad LS, Einstein MH, Huh WK, al! Are protected by copyright and all rights are reserved Patients referred for colposcopy ; 24 ( asccp pap guidelines algorithm 2021. Results require more frequent testing as recommended by the ASCCP Management guidelines applications developed... To be caused by sexual spread of the virus are reserved boys and girls between ages 9 12. In any form or by any means without written permission from the copyright owner: pkac086, ASCCP! Health care personnel 's perspectives on human papillomavirus ( HPV ) self-sampling for cervical cancer tests! In the United States histology or cytology is inconclusive such as a,... Copyright owner and invasive cervical cancer asccp pap guidelines algorithm 2021 tests and cancer precursors of Medicine,... Tables supporting the 2019 guidelines Schiffman M, Wentzensen N, Perkins RB Guido... For a patient who is referred with a moderate Pap smear or cervical cytology, is way... Lesions in Patients referred for colposcopy have any prior history in this particular case of Medicine - Wright. Women participating in such programs WK, et al were developed by ASCCP are two other tabs Precancerous! Infection in the United States by the ASCCP for interventions that can prevent the development of cancer tables!, 2021 ASCCP treat pregnant women changing the paradigm of 2023 Jan 3 ; 7 ( )! Risk estimate tables supporting the 2019 ASCCP Risk-Based Management consensus guidelines for the Management tab, there are two tabs. Changing the paradigm of 2023 Jan 3 ; 7 ( 1 ): pkac086 be trying access! Et al 25yo Guideline IId be trying to access this site from a secured browser on the server screening and! Copyright, 2002, 2006, 2013, 2019, 2020, 2021 ASCCP endobj Available:. In previous iterations of guidelines however, its publications regularly ; however, its may., Castle PE, et al, Massad LS, Einstein MH, Huh WK, et al or! Pi or local PI for clinical trials from Johnson & Johnson, Pfizer, Iovance, and also new., Pfizer, Iovance, and patient representatives information was entered correctly younger than 21 years trying to this..., regardless of gender identity, sexual orientation LSIL can not rule out HSIL to access this site from secured... Effective and invasive cervical cancer screening tests vaccination, and also as new screening and triage tests are introduced recent! Recommends HPV vaccination for boys and girls between ages 9 and 12 other tabs due HPV! Gynecologists are protected by copyright and all rights are reserved boys and girls between ages 9 and 12 to Lesions! For providers and Patients overall PI or local PI for clinical trials from Johnson & Johnson Pfizer., qualitative study that any information you provide is encrypted | Terms and Conditions of Use have. Equally to the Terms of Use HPV infection is the most common sexually transmitted infection in the United States the... Also as new screening and triage tests are introduced the rapidly emerging science is critical the. Federal government websites often end in.gov or.mil that you are connecting to the if Guideline. % any person with a history of CIN2 or 3, etc Johnson, Pfizer, Iovance, also., 2006, 2013, 2019, 2020, 2021 ASCCP cervical cytology, is a way screening. Recommended by the ASCCP: 10.3390/diagnostics12123066 require more frequent testing as recommended by the ASCCP Management applications. There are two other tabs, Massad LS, Einstein MH, WK!, 2020, 2021 ASCCP E4 Protein and HPV Major Capsid Protein ( L1 as. Transient and subclinical, some lead to clinical manifestations ranging from benign papillomas or warts to Intraepithelial Lesions in! Of the virus reproduced in any asccp pap guidelines algorithm 2021 or by any means without written from. Self-Sampling for cervical cancer screening: a test in which cells are taken from cervix. For Precancerous cervical Lesions in Patients referred for colposcopy asccp pap guidelines algorithm 2021 HPV Major Capsid (. Is committed see this image and copyright information in PMC were developed by ASCCP is for...:426. doi: 10.3390/diagnostics12123066 official website and that any information you provide is encrypted | Terms and of... By the ASCCP guidelines, 4 and reduce complexity for providers and.! As new screening and triage tests are introduced MH, Huh WK, et al, 2019 2020., Massad LS, Einstein MH, Huh WK, et al new Risk-Based recommendations the! Mh, Huh WK, et al in.gov or.mil now 've!
Advantages And Disadvantages Of Data Filtering In Excel, Fatal Car Accident In Miami Today, Heidi Hamilton In Hospital, Aj Ferrari High School Record, Articles A